Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

12.04GBp
11:35am EDT
Change (% chg)

0.04 (+0.33%)
Prev Close
12.00
Open
11.98
Day's High
12.12
Day's Low
11.84
Volume
3,056,997
Avg. Vol
8,210,306
52-wk High
13.19
52-wk Low
4.44

Select another date:

Fri, Mar 9 2018

BRIEF-Oxford Biomedica Announces ‍Proposed Placing To Raise About 20.5 Mln STG

* OXFORD BIOMEDICA PLC - ‍PROPOSED PLACING TO RAISE APPROXIMATELY £20.5 MILLION​

Oxford BioMedica wins second $100 million gene therapy contract

LONDON Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.

Oxford BioMedica wins second $100 mln gene therapy contract

LONDON, Feb 15 Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.

BRIEF-Oxford Biomedica Says ‍Kymriah Receives Priority Review For Adult DLBCL​

* SAYS ‍KYMRIAH RECEIVES PRIORITY REVIEW FOR ADULT DLBCL​ Source text for Eikon: Further company coverage:

Select another date: